News tagged with biopharmaceutical company
New data show breakthrough microRNA-targeted therapy holds promise as new treatment for hepatitis C
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S, holds promise as a novel treatment for patients infected with the Hepatitis C viru ...
Medicine & Health / Diseases, Conditions, Syndromes
Dec 03, 2009 |
5 / 5 (2) |
0
Search results for biopharmaceutical company
Millennial Media shares nearly double in debut
(AP) -- Shares of Millennial Media nearly doubled in the mobile advertising company's market debut Thursday.
Mar 29, 2012 |
not rated yet |
0
New method of bacterial cell engineering can produce better, cheaper drug therapies
(PhysOrg.com) -- Escherichia coli – a bacteria considered the food safety bane of restaurateurs, grocers and consumers – is a friend. Cornell University biomolecular engineers have learned to use ...
Mar 26, 2012 |
5 / 5 (2) |
0
|
Fastest X-ray images of tiny biological crystals
(PhysOrg.com) -- An international research team headed by DESY scientists from the Center for Free-Electron Laser Science (CFEL) in Hamburg, Germany, has recorded the shortest X-ray exposure of a protein crystal ...
Jan 05, 2012 |
4 / 5 (4) |
5
Google-backed 23andMe hits major milestone: 100,000 users in DNA database
Mountain View, Calif., genomics startup 23andMe just hit a milestone: As of Wednesday, 100,000 people have uploaded their genetic code to the 4-year-old company's database.
Jun 16, 2011 |
5 / 5 (2) |
0
New cancer drug discovered at U-M heads to clinical trials
Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug called AT-406 with potential to treat multiple types of cancer.
Mar 29, 2011 |
5 / 5 (2) |
0
Tiny LNA-based compounds inhibit entire disease-associated microRNA families
A study published online in this week's Nature Genetics demonstrates that tiny Locked Nucleic Acid (LNA)-based compounds developed by Santaris Pharma A/S can inhibit entire disease-associated microRNA families. This provid ...
Mar 20, 2011 |
5 / 5 (1) |
1
|
Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients
The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in co ...
Medicine & Health / Diseases, Conditions, Syndromes
Mar 15, 2011 |
not rated yet |
0
HP speeds drug discovery research with inkjet technology
HP today announced an innovative drug research application for its inkjet technology that enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages.
Medicine & Health / Medications
Mar 11, 2011 |
not rated yet |
0
Potential treatment for Chikungunya discovered
The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS, a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal ...
Medicine & Health / Diseases, Conditions, Syndromes
Feb 16, 2011 |
5 / 5 (2) |
0
Adrenaline receptor 'frozen in action'
Adrenaline, the hormone that prepares our body to fight or flight, acts on a hyperdynamic receptor. This molecule switches so fast between several positions, that it was impossible to image it. Until now. Scientists, including ...
Medicine & Health / Medical research
Jan 12, 2011 |
not rated yet |
0
List of search results for biopharmaceutical company
